BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16642489)

  • 1. Effect of race on outcome of white and black children with acute myeloid leukemia: the St. Jude experience.
    Rubnitz JE; Lensing S; Razzouk BI; Pounds S; Pui CH; Ribeiro RC
    Pediatr Blood Cancer; 2007 Jan; 48(1):10-5. PubMed ID: 16642489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma.
    Kahn JM; Keegan TH; Tao L; Abrahão R; Bleyer A; Viny AD
    Cancer; 2016 Sep; 122(17):2723-30. PubMed ID: 27286322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid Leukemia.
    Lamba JK; Marrero R; Wu H; Cao X; Parcha PK; Karol SE; Inaba H; Kuo DJ; Degar BA; Heym K; Taub JW; Lacayo NJ; Pui CH; Ribeiro RC; Pounds SB; Rubnitz JE
    JAMA Netw Open; 2024 May; 7(5):e2411726. PubMed ID: 38753328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of acuity of illness at presentation in early mortality in black children with acute myeloid leukemia.
    Winestone LE; Getz KD; Miller TP; Wilkes JJ; Sack L; Li Y; Huang YS; Seif AE; Bagatell R; Fisher BT; Epstein AJ; Aplenc R
    Am J Hematol; 2017 Feb; 92(2):141-148. PubMed ID: 27862214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparable on-therapy mortality and supportive care requirements in Black and White patients following initial induction for pediatric acute myeloid leukemia.
    Li Y; Newton JG; Getz KD; Huang YS; Seif AE; Fisher BT; Aplenc R; Winestone LE
    Pediatr Blood Cancer; 2019 Apr; 66(4):e27583. PubMed ID: 30585685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of poverty and race on outcomes in acute myeloid leukemia.
    Byrne MM; Halman LJ; Koniaris LG; Cassileth PA; Rosenblatt JD; Cheung MC
    Am J Clin Oncol; 2011 Jun; 34(3):297-304. PubMed ID: 20562587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-hospital Mortality and Racial Disparity in Children and Adolescents With Acute Myeloid Leukemia: A Population-based Study.
    Castellanos MI; Dongarwar D; Wanser R; Caceres I; Park C; Rodriguez J; Salihu HM
    J Pediatr Hematol Oncol; 2022 Jan; 44(1):e114-e122. PubMed ID: 34001781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of treatment for childhood cancer in black as compared with white children. The St Jude Children's Research Hospital experience, 1962 through 1992.
    Pui CH; Boyett JM; Hancock ML; Pratt CB; Meyer WH; Crist WM
    JAMA; 1995 Feb; 273(8):633-7. PubMed ID: 7844873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Adolescents and Young Adults With Acute Myeloid Leukemia Treated in a Single Latin American Center.
    Jaime-Pérez JC; Padilla-Medina JR; Fernández LT; Herrera-Garza JL; Gutiérrez-Aguirre CH; Tarín-Arzaga L; Gómez-Almaguer D
    Clin Lymphoma Myeloma Leuk; 2018 Apr; 18(4):286-292. PubMed ID: 29478946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of pediatric patients with acute myeloid leukemia (AML) and -5/5q- abnormalities from five pediatric AML treatment protocols: a report from the Children's Oncology Group.
    Johnston DL; Alonzo TA; Gerbing RB; Hirsch B; Heerema NA; Ravindranath Y; Woods WG; Lange BJ; Gamis AS; Raimondi SC
    Pediatr Blood Cancer; 2013 Dec; 60(12):2073-8. PubMed ID: 24039149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes of pediatrics acute myeloid leukemia (AML) and associated factors in the country's tertiary referral hospital, Ethiopia.
    Mamo W; Moges A; Yesuf SA; Mohamedsaid A; Arega G
    BMC Cancer; 2024 May; 24(1):640. PubMed ID: 38789952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in presentation, referral and treatment patterns and survival in adult patients with acute myeloid leukemia: a single-institution experience.
    Bierenbaum J; Davidoff AJ; Ning Y; Tidwell ML; Gojo I; Baer MR
    Leuk Res; 2012 Feb; 36(2):140-5. PubMed ID: 22112974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial.
    Quarello P; Fagioli F; Basso G; Putti MC; Berger M; Luciani M; Rizzari C; Menna G; Masetti R; Locatelli F
    Br J Haematol; 2015 Nov; 171(4):566-73. PubMed ID: 26223157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successive clinical trials for childhood acute myeloid leukemia at St Jude Children's Research Hospital, from 1980 to 2000.
    Ribeiro RC; Razzouk BI; Pounds S; Hijiya N; Pui CH; Rubnitz JE
    Leukemia; 2005 Dec; 19(12):2125-9. PubMed ID: 16281077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children's Cancer Study Group.
    O'Brien TA; Russell SJ; Vowels MR; Oswald CM; Tiedemann K; Shaw PJ; Lockwood L; Teague L; Rice M; Marshall GM;
    Blood; 2002 Oct; 100(8):2708-16. PubMed ID: 12351376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007.
    Pui CH; Pei D; Pappo AS; Howard SC; Cheng C; Sandlund JT; Furman WL; Ribeiro RC; Spunt SL; Rubnitz JE; Jeha S; Hudson MM; Kun LE; Merchant TE; Kocak M; Broniscer A; Metzger ML; Downing JR; Leung W; Evans WE; Gajjar A
    J Clin Oncol; 2012 Jun; 30(16):2005-12. PubMed ID: 22547602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
    Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
    Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocation t(9;11)(p21;q23) in pediatric de novo and secondary acute myeloblastic leukemia.
    Sandoval C; Head DR; Mirro J; Behm FG; Ayers GD; Raimondi SC
    Leukemia; 1992 Jun; 6(6):513-9. PubMed ID: 1602790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in childhood AML in the absence of transplantation in first remission--Children's Cancer Group (CCG) studies 2891 and CCG 213.
    Castellino SM; Alonzo TA; Buxton A; Gold S; Lange BJ; Woods WG
    Pediatr Blood Cancer; 2008 Jan; 50(1):9-16. PubMed ID: 17252564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961.
    Barbaric D; Alonzo TA; Gerbing RB; Meshinchi S; Heerema NA; Barnard DR; Lange BJ; Woods WG; Arceci RJ; Smith FO
    Blood; 2007 Mar; 109(6):2314-21. PubMed ID: 17158236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.